Ernexa Therapeutics Inc.

Ownership Transactions Reported by 26 Insiders

Symbol
ERNA on Nasdaq
Industry
Pharmaceutical Preparations
Location
1035 Cambridge Street, Suite 18 A, Cambridge, MA

Insiders trading volume in the past year

Ernexa Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Matthew Angel President and CEO, Director $8.65M Jan 12, 2023
Charles Cherington 10%+ Owner $4.36M +$2.22M +104% Jun 9, 2025
Freebird Partners LP 10%+ Owner $1.5M Dec 14, 2023
George P. Denny III 10%+ Owner $1.13M Dec 2, 2022
John D. Halpern 10%+ Owner $1.12M Dec 2, 2022
Nicholas J. Singer Director $1.03M Dec 2, 2022
Roger Sidhu Chief Medical Officer $200K Sep 20, 2022
Kevin DAmour Chief Scientific Officer $159K Jun 28, 2022
Jay Sial Chief Administration Officer $88.5K Mar 11, 2022
Binder Brant Former director $10.5K Aug 8, 2023
Richard W. Wagner Former director $10.5K Aug 8, 2023
Sandra Gurrola Sr. VP of Finance $1.11K Jun 21, 2025
Erin S. Enright Director Jan 14, 2022
Howard J. Federoff CEO & President, Director Mar 11, 2022
Dennis Langer Director Dec 8, 2021
Erich Mohr Director Dec 8, 2021
Gregory Fiore Director Aug 1, 2022
Heather B. Redman Director Jan 14, 2022
Luba Greenwood Director Dec 8, 2021
Andrew Jackson Chief Financial Officer Jun 3, 2022
William Wexler Director Feb 7, 2025
Elena Ratner Director Jan 13, 2025
James Arthur Bristol Director Feb 7, 2025
Sanjeev Luther President & CEO, Director Feb 7, 2025
Peter Cicala Director Feb 7, 2025
Dorothy Clarke General Counsel, Director Jan 1, 2024

Recent Insider Transactions by Companies or Individuals for Ernexa Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.